Commentary: What's the deal with menopause management? Why the Women's Health Initiative raises more questions than it answers.
Richardson
Marcie K
MK
Procter & Gamble Pharmaceuticals, Inc., USA. marcie_richardson@vmed.org
D003071:Cognition / Q000187:drug effects; D003863:Depression / Q000517:prevention & control; D004414:Dyspareunia / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000706:statistics & numerical data*; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006304:Health Status; D019584:Hot Flashes / Q000517:prevention & control; D006801:Humans; D007989:Libido / Q000187:drug effects; D008593:Menopause / Q000187:drug effects; D008796:Metrorrhagia / Q000517:prevention & control; D019964:Mood Disorders / Q000517:prevention & control; D011372:Progestins / Q000627:therapeutic use; D012893:Sleep Wake Disorders / Q000517:prevention & control; D014481:United States; D016387:Women's Health; D014932:Women's Health Services / Q000592:standards
D004967:Estrogens; D011372:Progestins